DUX4 and facioscapulohumeral muscular dystrophy: Although the picture is unlikely to be complete and a greater discovery of DUX4 expression factors are needed so that researchers could establish a more comprehensive pathogenic mechanism, these findings can still serve as novel therapeutic targets to treat FSHD.